Pancreatic Cancer Research

ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaActive in the last 2 years

Carlo Ingaldi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0478-9024; OpenAlex author ID A5024012401. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
71
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 3 papers · 2026: 3 papers

Papers 14

  1. Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. Co-author DOI 10.1001/jamanetworkopen.2026.35610↗
  2. Predictive factors for long-term survival in pancreatic ductal adenocarcinoma that underwent surgery: a systematic review and meta-analysis of literature. Co-author DOI 10.1007/s13304-025-02382-z↗
  3. The "Big short" of minimally invasive pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. A cost-effectiveness analysis based on randomized trials. Co-author DOI 10.1016/j.hpb.2025.10.014↗
  4. Pancreatic cancer and long survivors: a survey of Italian society of oncological surgery (SICO). First author DOI 10.1007/s13304-024-02039-3↗
  5. Stage IV pancreatic ductal adenocarcinoma (PDAC) with synchronous liver metastasis: are there survival benefits in liver resection? A systematic review and met… Co-author DOI 10.1016/j.ejso.2025.109598↗
  6. Pancreatic cancer resection in the elderly: state of the art, and future challenges. A systematic review. Co-author DOI 10.23736/s2724-5691.25.10527-3↗
  7. Clinicopathological predictive factors in long-term survivors who underwent surgery for pancreatic ductal adenocarcinoma: A single-center propensity score matc… Co-author DOI 10.1002/wjs.12397↗
  8. Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients. Co-author DOI 10.1097/sla.0000000000006166↗
  9. Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective,… Co-author DOI 10.3389/fnut.2023.1065294↗
  10. Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a r… Co-author DOI 10.3389/fnut.2023.1212436↗
  11. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre. Co-author DOI 10.1007/s13304-022-01346-x↗
  12. Improved survival after pancreatic re-resection of positive neck margin in pancreatic cancer patients. A systematic review and network meta-analysis. Co-author DOI 10.1016/j.ejso.2021.01.001↗
  13. Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials. Co-author DOI 10.1097/sla.0000000000005126↗
  14. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience. Co-author DOI 10.1007/s13304-020-00782-x↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Riccardo Casadei · 13 shared papers, 2020–2026 · strength 2.65
  2. Claudio Ricci · 12 shared papers, 2020–2026 · strength 2.55
  3. Vincenzo D’Ambra · 6 shared papers, 2024–2026 · strength 1.73
  4. Roberto Salvia · 5 shared papers, 2023–2026 · strength 0.78
  5. Massimo Falconi · 3 shared papers, 2021–2026 · strength 0.50
  6. Giuseppe Malleo · 3 shared papers, 2023–2024 · strength 0.45
  7. Erica Secchettin · 3 shared papers, 2023–2026 · strength 0.44
  8. Salvatore Paiella · 3 shared papers, 2023–2026 · strength 0.44
  9. Giovanni Luigi Capretti · 3 shared papers, 2023–2025 · strength 0.42
  10. Gabriella Lionetto Lionetto · 2 shared papers, 2024–2025 · strength 0.34
  11. Carla Serra · 3 shared papers, 2020–2022 · strength 0.33
  12. Mariacristina Di Marco · 3 shared papers, 2020–2022 · strength 0.33
  13. Francesco Minni · 3 shared papers, 2020–2022 · strength 0.33
  14. Stefano Crippa · 2 shared papers, 2021–2024 · strength 0.32
  15. Claudio Ricci · 2 shared papers, 2022–2025 · strength 0.28
  16. Matteo De Pastena · 2 shared papers, 2023 · strength 0.26
  17. Luca Vittorio Gianotti · 2 shared papers, 2023 · strength 0.26
  18. Darío Gregori · 2 shared papers, 2023 · strength 0.26
  19. Marta Sandini · 2 shared papers, 2023 · strength 0.26
  20. Ilaria Trestini · 2 shared papers, 2023 · strength 0.26
  21. Giulia Angela Zamboni · 2 shared papers, 2023 · strength 0.26
  22. Gennaro Nappo · 2 shared papers, 2023 · strength 0.26
  23. Laura Maggino · 2 shared papers, 2023 · strength 0.26
  24. Alessandro Zerbi · 2 shared papers, 2023 · strength 0.26
  25. Michèle Milella · 2 shared papers, 2023 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.